{"date":"2026-07-08","count":17,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4190-2026-07-08-1854-13kfgj2","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-07-08","time":"18:54:18","subject":"公告本公司董事因轉讓持股超過選任時持股二分之一，依法其董事職務當然解任","clause":"第6款","fact_date":"2026-06-02","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-07-08 18:54，「公告本公司董事因轉讓持股超過選任時持股二分之一，依法其董事職務當然解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-07-08-1751-190dlxh","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-07-08","time":"17:51:39","subject":"公告本公司與子公司源華智醫股份有限公司簽訂技術與專利申請權讓與合約","clause":"第10款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-07-08 17:51，「公告本公司與子公司源華智醫股份有限公司簽訂技術與專利申請權讓與合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-07-08-1727-6rqyk5","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-07-08","time":"17:27:42","subject":"公告本公司取得有價證券","clause":"第20款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-07-08 17:27，「公告本公司取得有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-07-08-1633-15tytup","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-07-08","time":"16:33:54","subject":"公告本公司副董事長辭任。","clause":"第6款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-07-08 16:33，「公告本公司副董事長辭任。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-07-08-1629-14xk7b4","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-07-08","time":"16:29:00","subject":"代子公司 FBD Biologics Limited 公告與應世生物科技（上海）有限公司簽訂戰略合作備忘錄（MOU）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-07-08 16:29，「代子公司 FBD Biologics Limited 公告與應世生物科技（上海）有限公司簽訂戰略合作備忘錄（MOU）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-07-08-1616-1qg8z9w","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-07-08","time":"16:16:17","subject":"公告本公司訂定除權息基準日相關事宜","clause":"第14款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-07-08 16:16，「公告本公司訂定除權息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-07-08-1615-19q70nd","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-07-08","time":"16:15:36","subject":"本公司受邀參加櫃買中心暨富邦證券舉辦之生技產業論壇","clause":"第12款","fact_date":"2026-07-16","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-07-08 16:15，「本公司受邀參加櫃買中心暨富邦證券舉辦之生技產業論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6446-2026-07-08-1610-1hkj5dk","company_id":"6446","company":"藥華藥","market":"上市","industry":"生技醫療","date":"2026-07-08","time":"16:10:17","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"第51款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：藥華藥（6446），2026-07-08 16:10，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-07-08-1550-1mqpohp","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-07-08","time":"15:50:18","subject":"公告本公司及代子公司Handa Pharma, Inc.及HandaOncology, LLC公告505(b)(2)新藥HND-039美國專利訴訟案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-07-08 15:50，「公告本公司及代子公司Handa Pharma, Inc.及HandaOncology, LLC公告505(b)(2)新藥」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-07-08-1547-ckq2dh","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-07-08","time":"15:47:44","subject":"公告本公司一一五年第一次現金增資因遇颱風影響而調整繳款期間事宜","clause":"第44款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-07-08 15:47，「公告本公司一一五年第一次現金增資因遇颱風影響而調整繳款期間事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-07-08-1537-1qkz1x4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-07-08","time":"15:37:06","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日","clause":"第14款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-07-08 15:37，「代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-07-08-1536-124ffeh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-07-08","time":"15:36:47","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利","clause":"第14款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-07-08 15:36，「代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-07-08-1533-19ws7nb","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-07-08","time":"15:33:17","subject":"公告本公司除息基準日","clause":"第14款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-07-08 15:33，「公告本公司除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-07-08-1528-1hkj5dk","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-07-08","time":"15:28:50","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"第51款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-07-08 15:28，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-07-08-1515-lnj9s3","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-07-08","time":"15:15:26","subject":"公告本公司初次申請股票上市時所出具之承諾事項執行情形","clause":"第51款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-07-08 15:15，「公告本公司初次申請股票上市時所出具之承諾事項執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-07-08-1504-1cp75gv","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-07-08","time":"15:04:28","subject":"本公司受邀參加群益金鼎證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-07-09","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-07-08 15:04，「本公司受邀參加群益金鼎證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-07-08-1434-1nxb0oo","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-07-08","time":"14:34:10","subject":"因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"第53款","fact_date":"2026-07-08","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-07-08 14:34，「因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}